Drug | Polymer | Result and Inferences | References |
---|---|---|---|
rhVEGF (human vascular endothelial growth factor) | Poly(lactic-co-glycolic acid); PLGA | Sustained order release of VEGF was observed for 2 weeks. Dynamic light scattering (DLS) showed monodispersed microparticles of small variation in micro particle size (<2%). | [36, 37] |
Etoposide | Poly (ε-caprolactone) | Sustained microsphere with narrow size distribution and smooth surface. | [38] |
Aspirin | Ethyl cellulose (EC), cellulose acetate phthalate (CAP) and their mixture (1:1) | Free flowing microspheres were observed. EC showed slower release rate than CAP and mixture. |
[39] |
Atenolol | Ethyl cellulose | Effect of various factors on release and entrapment was studied. | [40] |
Theophylline | Cellulose acetate | Good yield (87.5%) and good entrapment efficiency (92.4%) was observed. | [41] |
Telmisartan | Ethylcellulose | Hollow microsphere formation. | [42] |
Nifedipine | Eudragit RL100 | High drug-loading percent, successful retarding release (over 12 hours) and spherical and smooth surface morphology were obtained. | [43] |
Salbutamol sulphate | HPMC and Carbopol | Good entrapment efficiency was observed (68.3±0.01 and 94.9±0.02%). | [44] |
ValacyclovirHCl | Ethyl Cellulose | Floating microsphere could be obtained which will have high resident time in the upper part of GIT resulting in improved absorption. | [45] |
Captopril | Eudragit S100, Ethyl Cellulose | A sustained release was obtained. | [46] |
Stavudine | Ethylcellulose, Dibutylpthalate | Controlled release was obtained for a drug with very short half life. | [47] |
Boswellic acid | HPMC, Ethylcellulose | Increased gastric retention | [48] |
Ranitidine | HPMC K100, Xanthan gum, Eudragit S100 | Using acrylic and hydrophilic polymer, gastric residence time can be increased. | [49] |
Rosiglitazone maleate | HPMC, Ethylcellulose] | Decrease in gastric irritation, protection from gastric degradation | [50] |
Cephalexin | Ethylcellulose | Sustained effect | [51] |
Famotidine | Acrylocoat S100, cellulose acetate | The floating behavior, release rate and physical properties are affected. | [52] |
Cefpodoximeproxetil | HPMC K100 M, Ethylcellulose | Sustained effect | [53] |
Rabeprazol sodium | HPMC, Methyl cellulose | Improved short half life and prevention of degradation of drug from lower part of stomach | [54] |
Clarithromycin | HPMC 15M, K4M, 100LV, Ethylcellulose | Sustained effect | [55] |
Cimetidine | HPMC, Ethylcellulose | Sustained effect | [56] |